Skip to main content
OpenTrials
Completed

NCT Number: NCT00894140

Study to Assess the Stability, Efficacy and Safety of the Silent™ Hip Prosthesis in Primary Total Hip Replacement

The purpose of this study is to determine if the Silent™ hip, when used as part of an artificial hip joint, is stable and effective in treatment of patients with joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical, standard and special x-rays (RSA) to allow the position of the Silent Hip within the bone to be accurately monitored.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sydney Adventist Hospital, Sydney, Australia

Loading trial locations.

About this study

The Primary Objective of this study was to evaluate the short-term stability of the Silent Hip, implanted using a manual or navigated technique, using radiostereometric analysis (RSA). The study was also intended to provide the clinical data necessary to demonstrate conformance with the essential requirements of the Medical Device Directive. Secondary objectives were to determine the efficacy of the Silent™ Hip femoral prosthesis from a clinical and radiological prospective, to assess the safety of the device and to evaluate the impact of the procedure on the Subjects' Quality of Life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects, aged between 25 and 65 years inclusive.
  • Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • Subjects with non-inflammatory osteoarthritis of the hip who require a primary total hip replacement.

Exclusion criteria

  • Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
  • Women who are pregnant.
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
  • Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
  • Subjects who are currently involved in any injury litigation claims.
  • Subjects who have osteonecrosis of the femoral neck
  • Subjects who have an existing contralateral hip, ankle or knee replacement or an ipsilateral knee or ankle replacement or any metal implant in the lower lumber spine (navigated cases only).
  • Subjects who are greater than 90kg in weight.
  • Subject who have a CCD angle of the anatomical femur less than 125˚
  • Subjects with significant bone loss or gross deformity in the region of the neck of the femur as identified on the pre-operative radiographs, where in the Investigator's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the prosthesis.
  • Subjects with a Charnley C classification.
  • Subjects with an active local or systemic infection.
  • Subjects with loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the arthroplasty procedure unjustified.
  • Subjects with Paget's disease
  • Subjects who still plan in the future to have children.

Treatment and study plan

DePuy Silent™ Hip femoral prosthesis

Device

A short cementless, femoral component for use in total hip arthroplasty

Primary outcomes

  1. The translational and rotational movements of the Silent™ hip in the 3 dimensions from the baseline position (determined from the 7 day post-operative RSA x-rays) to the 1 year follow-up visit.

    Time frame: 1year post-surgery

Secondary outcomes

  1. Kaplan Meier survivorship of the Silent Hip prosthesis in terms of revision and radiological aseptic loosening

    Time frame: 1 year

  2. Difference demonstrated between pre-op and 5 year Harris Hip Score

    Time frame: 5 years post surgery

  3. Difference demonstrated between pre-op and 5 year Oxford Hip Score

    Time frame: 5years post surgery

  4. Incidence of radiological signs on the post-operative x-rays

    Time frame: 3 months post surgery

  5. Difference demonstrated between pre-op and 10 year Harris Hip Score

    Time frame: 10 years post surgery

  6. Difference demonstrated between pre-op and 10 year Oxford Hip Score

    Time frame: 10 years post surgery

  7. Incidence of radiological signs on the post-operative x-rays

    Time frame: 6 months post surgery

  8. Incidence of radiological signs on the post-operative x-rays

    Time frame: 1 year post surgery

  9. Incidence of radiological signs on the post-operative x-rays

    Time frame: 18 months post surgery

  10. Incidence of radiological signs on the post-operative x-rays

    Time frame: 2 years post surgery

  11. Incidence of radiological signs on the post-operative x-rays

    Time frame: 5 years post surgery

  12. Incidence of radiological signs on the post-operative x-rays

    Time frame: 10 years post surgery

  13. Kaplan Meier survivorship of the Silent Hip prosthesis in terms of revision and radiological aseptic loosening

    Time frame: 2 years

  14. Kaplan Meier survivorship of the Silent Hip prosthesis in terms of revision and radiological aseptic loosening

    Time frame: 5 years

  15. Kaplan Meier survivorship of the Silent Hip prosthesis in terms of revision and radiological aseptic loosening

    Time frame: 10 years

Sponsors and collaborators

Lead sponsor

DePuy International

Industry

Collaborators

  • Johnson and Johnson Medical

Registry information

Official study title

A Non-comparative, Two Centre, EN540, RSA, Pilot Study to Evaluate the Stability, Efficacy and Safety of the Silent Hip Prosthesis in Primary Total Hip Replacement

Important dates

Study start
2003
Primary completion
2004
Study completion
2014
First posted
May 6, 2009
Registry last updated
Sep 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.